Fundraising Fox
Vero Bioscience
1 known investors
Find your way into Vero Bioscience
84 people in our graph can introduce you to the Vero Bioscience team.
Sign up to see every warm intro you have to Vero Bioscience
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Vero Bioscience team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Vero BioScience develops a blood-based proteomic test that measures organ-specific protein signatures to assess the biological age of individual organs and detect early signs of age-related disease. The company targets individuals seeking predictive health insights and preventive medicine interventions based on technology developed at Stanford.
Founders & leadership
TW
Tony Wyss-CorayCo-founder
PC
Paul ColettaPaul Coletta has spent over 25 years scaling consumer and health brands. He is co-founder and CEO of Vero BioScience, which develops blood-based proteomic tests to assess organ-specific biological age and detect early signs of age-related disease.
MO
Markus Okumus
Investors · 1
Khosla Ventureslisted by Khosla VenturesMenlo Park · $100K – $20M
How we know: Khosla Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
Related companies · 5
VERO BiotechVERO Biotech develops next-generation inhaled nitric oxide (iNO) delivery systems for patients with cardiopulmonary conditions in acute care hospital settings. The company focuses on designing and commercializing innovative medical devices to address unmet clinical needs.
Verana HealthVerana Health aggregates de-identified clinical data from a network of over 20,000 physicians in ophthalmology, urology, and neurology to power real-world evidence, clinical trial enablement, and quality reporting for pharmaceutical companies and healthcare providers using AI and machine learning.
VeratxVera Therapeutics develops medicines targeting autoimmune-driven kidney diseases, with a focus on reducing the need for dialysis or transplant. The company was founded by a physician and operates as a clinical-stage biotech with a patient-centered approach to drug development.
LabcorpLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.
Life BiosciencesLife Biosciences is a biopharmaceutical company developing therapies focused on aging and age-related diseases, working across gene therapy and neuroscience programs. It advances drug candidates from discovery through clinical development.
Companies working in the same space as Vero Bioscience.
Frequently asked questions
- What does Vero Bioscience do?
- Vero BioScience develops a blood-based proteomic test that measures organ-specific protein signatures to assess the biological age of individual organs and detect early signs of age-related disease. The company targets individuals seeking predictive health insights and preventive medicine interventions based on technology developed at Stanford.
- Who founded Vero Bioscience?
- Vero Bioscience was founded by Tony Wyss-Coray.
- Who are Vero Bioscience's investors?
- Vero Bioscience's investors include Khosla Ventures.